| pubmed-article:11177250 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11177250 | lifeskim:mentions | umls-concept:C0030567 | lld:lifeskim |
| pubmed-article:11177250 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:11177250 | lifeskim:mentions | umls-concept:C0042036 | lld:lifeskim |
| pubmed-article:11177250 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
| pubmed-article:11177250 | lifeskim:mentions | umls-concept:C0007412 | lld:lifeskim |
| pubmed-article:11177250 | lifeskim:mentions | umls-concept:C0870883 | lld:lifeskim |
| pubmed-article:11177250 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:11177250 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:11177250 | pubmed:dateCreated | 2001-2-22 | lld:pubmed |
| pubmed-article:11177250 | pubmed:abstractText | The content of catecholamines and their metabolites in the brain and the relationship between cerebral catecholamine levels and their urinary excretion were studied in rats with 6-OHDA-induced hemiparkinsonism. 6-OHDA reduced brain concentrations of dopamine, DOPAC, and homovanilic acid and urinary excretion of dopamine, dioxyphenilalanine, and DOPAC by more than 90%. A positive correlation was found between the concentrations of these metabolites in the urine and striatum. Measurement of urinary catecholamines and their metabolites is a perspective test for evaluating the status of the dopaminergic nigrosostriate system of the brain in experimental parkinsonism. | lld:pubmed |
| pubmed-article:11177250 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11177250 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11177250 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11177250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11177250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11177250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11177250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11177250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11177250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11177250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11177250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11177250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11177250 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11177250 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:11177250 | pubmed:issn | 0007-4888 | lld:pubmed |
| pubmed-article:11177250 | pubmed:author | pubmed-author:LebedevS VSV | lld:pubmed |
| pubmed-article:11177250 | pubmed:author | pubmed-author:KoganB MBM | lld:pubmed |
| pubmed-article:11177250 | pubmed:author | pubmed-author:SavchenkoE... | lld:pubmed |
| pubmed-article:11177250 | pubmed:author | pubmed-author:ChekhoninV... | lld:pubmed |
| pubmed-article:11177250 | pubmed:author | pubmed-author:FilatovaT STS | lld:pubmed |
| pubmed-article:11177250 | pubmed:author | pubmed-author:DmitrievaT... | lld:pubmed |
| pubmed-article:11177250 | pubmed:author | pubmed-author:BaklaushevV... | lld:pubmed |
| pubmed-article:11177250 | pubmed:author | pubmed-author:Man'kovskayaI... | lld:pubmed |
| pubmed-article:11177250 | pubmed:author | pubmed-author:YusupovaI UIU | lld:pubmed |
| pubmed-article:11177250 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11177250 | pubmed:volume | 130 | lld:pubmed |
| pubmed-article:11177250 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11177250 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11177250 | pubmed:pagination | 805-9 | lld:pubmed |
| pubmed-article:11177250 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:meshHeading | pubmed-meshheading:11177250... | lld:pubmed |
| pubmed-article:11177250 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11177250 | pubmed:articleTitle | Catecholamines and their metabolites in the brain and urine of rats with experimental Parkinson's disease. | lld:pubmed |
| pubmed-article:11177250 | pubmed:affiliation | V. P. Serbskii State Center of Social and Forensic Psychiatry, Moscow. | lld:pubmed |
| pubmed-article:11177250 | pubmed:publicationType | Journal Article | lld:pubmed |
